Skip to main content
PMC home page
Cell Death & Disease logoLink to Cell Death & Disease
. 2022 Oct 7;13(10):854. doi: 10.1038/s41419-022-05252-3

Retraction Note to: RIPK3 interactions with MLKL and CaMKII mediate oligodendrocytes death in the developing brain

Yi Qu 1,2,✉,#, Jun Tang 1,2,#, Huiqing Wang 1,2, Shiping Li 1,2, Fengyan Zhao 1,2, Li Zhang 1,2, Q Richard Lu 1,2,3, Dezhi Mu 1,2,4,✉
PMCID: PMC9546882  PMID: 36207298

Retraction to: Cell Death and Disease 10.1038/cddis.2017.54, published online 23 February 2017

The Editors have retracted this article. Concerns have been raised regarding a number of figures, specifically:

  • Figure 7a: there appear to be a number of repeating features in the bottom four panels.

  • Figure 7b: there appear to be a number of repeating features in the bottom four panels.

  • Figure 8b: there appear to be a number of repeating features in the panels for S, HI and RIPK3/Si for MPB(P21).

Additionally, the article shows significant overlap with a previously published article [1]. The Editors therefore no longer has confidence in the reliability of this article.

The authors have not responded to any correspondence from the editor/publisher about this retraction notice.

Footnotes

These authors contributed equally: Yi Qu, Jun Tang.

Contributor Information

Yi Qu, Email: quyi712002@163.com.

Dezhi Mu, Email: mudz@scu.edu.cn.

Reference

  • 1.Qu Y, Shi J, Tang Y, Zhao F, Li S, Meng J, et al. MLKL inhibition attenuates hypoxia-ischemia induced neuronal damage in developing brain. Exp Neurol. 2016;279:223–31. doi: 10.1016/j.expneurol.2016.03.011. [DOI] [PubMed] [Google Scholar]

Articles from Cell Death & Disease are provided here courtesy of Nature Publishing Group

RESOURCES